Olga Sanchez Negrette

Summary

Affiliation: Universidad Nacional de Salta
Country: Argentina

Publications

  1. ncbi High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina
    Olga Sanchez Negrette
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Calle Buenos Aires, Salta, Argentina
    Pediatrics 115:e668-72. 2005
  2. ncbi Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease
    Olga Sanchez Negrette
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Calle Buenos Aires 177, 4400 Salta, Argentina
    Clin Vaccine Immunol 15:297-302. 2008
  3. ncbi Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease
    Carolina Davies
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, CONICET, Universidad Nacional de Salta, Avda Bolivia 5150, Salta 4400, Argentina
    Antimicrob Agents Chemother 54:3584-9. 2010
  4. ncbi Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology
    María Celia Mora
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Argentina
    J Parasitol 91:1468-73. 2005

Collaborators

Detail Information

Publications4

  1. ncbi High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina
    Olga Sanchez Negrette
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Calle Buenos Aires, Salta, Argentina
    Pediatrics 115:e668-72. 2005
    ....
  2. ncbi Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease
    Olga Sanchez Negrette
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Calle Buenos Aires 177, 4400 Salta, Argentina
    Clin Vaccine Immunol 15:297-302. 2008
    ..Recombinant antigen 13 might be a good marker of treatment effectiveness, since 66.6% (six of nine) of the patients presented with an early regression to negativity for specific antibodies to this antigen (P = 0.002)...
  3. ncbi Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease
    Carolina Davies
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, CONICET, Universidad Nacional de Salta, Avda Bolivia 5150, Salta 4400, Argentina
    Antimicrob Agents Chemother 54:3584-9. 2010
    ..The present evidence suggests that NFOH is a promising anti-T. cruzi agent...
  4. ncbi Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology
    María Celia Mora
    Instituto de Patologia Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Argentina
    J Parasitol 91:1468-73. 2005
    ....